Diabetes Screening in Cystic Fibrosis Patients
Abstract Diabetes Screening in Cystic Fibrosis Patients aimed to increase the oral glucose tolerance test (OGTT) completion rate (CR) for cystic fibrosis-related diabetes (CFRD) in cystic fibrosis (CF) patients at an academic medical center. Objectives included implementing a patient education system about CFRD and the OGTT, implementing an outpatient reminder system for screening, evaluating program effectiveness, analyzing descriptive data, and creating a sustainable program for CFRD screening. A prospective design was used to evaluate the CR of screening in CF patients over a three-month period in 2017. Retrospective chart audits were used to compare historical data from a similar time period in 2016. Data obtained during the project were compared to historical and national data from 2016. Participants were adult patients with CF and without an existing diagnosis of CFRD. A generalized estimating equation and tests of proportions compared groups. The variables age, gender, insurance status, and lung disease severity were measured using chi square tests and two sample t-tests. The project 38.7% CR exceeded the 23.1% CR from the year before (p = 0.04) and the similar time period in 2016 of 9.8% (p = 0.002). The project OGTT CR did not show statistically significant improvement above the 2016 national average and was below the 2016 average of the top 10 CF performing centers. Age, gender, insurance status, and lung disease severity had no effect on OGTT CRs. A structured program increased CRs at the medical center. Information gained may positively impact treatment and reduce complications associated with CFRD.
|Work Title||Diabetes Screening in Cystic Fibrosis Patients|
|License||All rights reserved|
|Publication Date||April 23, 2018|
|Deposited||April 23, 2018|
This resource is currently not in any collection.